# Horizon 3 Healthcare

> Horizon 3 Healthcare is a VC fund backing Health Care and Medical Device. See 2 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Melbourne, Australia
- Total investments: 2
- Last investment: Jul 2026
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/horizon-3-healthcare
- Website: https://h3healthcare.com.au

Horizon 3 Healthcare is a VC fund in Melbourne focused on Health Care and Medical Device. H3 Healthcare focuses on investing in growth-stage healthcare companies that have achieved clinical validation and are generating revenue.

## Contacts

5 contacts available for Horizon 3 Healthcare. Shizune tracks 1 team members at Horizon 3 Healthcare. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/horizon-3-healthcare?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 100% |
| Medical Device | 2 | 100% |
| Therapeutics | 1 | 50% |
| Biotechnology | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series E | 1 | 50% |
| Venture - Series Unknown | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Switzerland | 1 | 50% |
| United States | 1 | 50% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Matt McNamara | CIO & Director | 4 | https://shizune.co/investors/profile/matt-mcnamara |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Xeltis | A clinical-stage medical device company, Xeltis has developed the most advanced polymer-based restorative devices for cardiovascular treatment. Xeltis’ restorative devices include implantable small diameter blood vessels for hemodialysis vascular access and for coronary artery bypass graft (CABG) surgery and pulmonary heart valves, for whichclinical trials are ongoing. Xeltis was formed through the merger of two Dutch/Swiss university spin-offs. It currently has operations in The Netherlands and in the USA. Xeltis’ investors include venture capital funds EQT Life Sciences, Kurma Partners, VI Partners and Ysios Capital as well as a number of private investors. In 2021, Xeltis secured a €15 million financing from the European Investment Bank and a €15 million funding from the European Innovation Council Accelerator (EIC) set up by the European Commission. | $23.3M | Venture - Series Unknown | Jul 28, 2026 |  |
| Cardiac Dimensions | Cardiac Dimensions, Inc. is a medical device company developing novel interventional tools for the treatment of heart failure and the related condition of mitral valve regurgitation. Our product, the Carillon® Mitral Contour System®, is a groundbreaking, non-surgical device developed to treat functional mitral valve regurgitation. Our system uses acatheter based approach to reshape the mitral valve and reduce mitral regurgitation. | $53M | Series E | Mar 20, 2025 |  |

2 of 2 investments shown.

## Co-investors
- [European Innovation Council](https://shizune.co/investors/profile/european-innovation-council) — VC Fund, 2 deals together
- [Ally Bridge Group](https://shizune.co/investors/profile/ally-bridge-group) — VC Fund, 1 deal together
- [DaVita Venture Group](https://shizune.co/investors/profile/davita-venture-group) — VC Fund, 1 deal together
- [Claret Capital Partners](https://shizune.co/investors/profile/harbert-european-growth-capital) — VC Fund, 1 deal together
- Horizon 3 — VC Fund, 1 deal together
- [Hostplus](https://shizune.co/investors/profile/hostplus) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Krungsri Finnovate](https://shizune.co/investors/profile/krungsri-finnovate) — VC Fund
- [Munich Venture Partners](https://shizune.co/investors/profile/munich-venture-partners) — VC Fund
- [yet2Ventures](https://shizune.co/investors/profile/yet2ventures) — VC Fund

## FAQ

### What does Horizon 3 Healthcare invest in?

Horizon 3 Healthcare invests primarily in Health Care, Medical Device and Therapeutics startups, most often at Series E and Venture - Series Unknown stage. Most of the 2 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Horizon 3 Healthcare?

Public channels for Horizon 3 Healthcare include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Horizon 3 Healthcare?

The team at Horizon 3 Healthcare includes Matt McNamara (CIO & Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co